Aerovate Therapeutics, Inc.
NASDAQ:AVTE
2.72 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -75.521 | -51.511 | -22.963 | -9.611 | -3.33 |
| Depreciation & Amortization
| 0.096 | 0.068 | 0.015 | 0.001 | 0 |
| Deferred Income Tax
| 0.164 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 11.906 | 5.476 | 2.043 | 0.058 | 0 |
| Change In Working Capital
| 9.798 | 7.755 | -6.51 | 0.974 | 0.549 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -0.164 | 1.368 | 0.609 | 0.037 | 0.436 |
| Other Working Capital
| 9.962 | 6.387 | -7.119 | 0.937 | 0.113 |
| Other Non Cash Items
| -3.221 | -0.91 | 0.016 | 0.719 | -0.436 |
| Operating Cash Flow
| -56.778 | -39.122 | -27.399 | -7.859 | -2.781 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -0.142 | -0.195 | -0.181 | 0 | 0 |
| Acquisitions Net
| -0.012 | -0.007 | 0 | 0 | 0 |
| Purchases Of Investments
| -123.982 | -147.623 | -113.253 | 0 | 0 |
| Sales Maturities Of Investments
| 136 | 154.744 | 0 | 0 | 0 |
| Other Investing Activites
| 0.012 | 0.007 | -0.113 | 0 | 0 |
| Investing Cash Flow
| 11.876 | 6.926 | -113.434 | 0 | 0 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | 0 | 0 | -2.5 | -2.5 |
| Common Stock Issued
| 45.996 | 0.15 | 126.945 | 6.418 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -0.234 | 0.246 | 63.512 | 5 | 5 |
| Financing Cash Flow
| 45.996 | 0.396 | 190.457 | 8.918 | 2.5 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 1.094 | -31.8 | 49.624 | 1.059 | -0.281 |
| Cash At End Of Period
| 23.491 | 22.397 | 54.197 | 4.573 | 3.514 |